23 Mar 2018 - Fisher and Paykel’s (ASX:FPH) Optiflow nasal high flow therapy has shown significant benefits for children in new Australian research.
This exclusive 48-hour opportunity is available only to DealRoom members.
Sign up now to access the deal - and get early access to future offerings.
91 views
SUMMARY
23 Mar 2018 - Fisher and Paykel’s (ASX:FPH) Optiflow nasal high flow therapy has shown significant benefits for children in new Australian research.
POST YOUR COMMENT
COMMENTS